• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach.采用平衡法确认芬氟拉明对 [(11)C]AZ10419369 与 5-HT(1B) 受体结合的影响。
J Cereb Blood Flow Metab. 2012 Apr;32(4):685-95. doi: 10.1038/jcbfm.2011.172. Epub 2011 Dec 14.
2
Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain.芬氟拉明诱导的血清素释放降低了灵长类动物大脑中 5-HT1B 受体对 [11C]AZ10419369 的结合。
Synapse. 2010 Jul;64(7):573-7. doi: 10.1002/syn.20780.
3
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.芬氟拉明降低非人类灵长类动物大脑中 [11C]Cimbi-36 与 5-HT2A 受体的结合。
Int J Neuropsychopharmacol. 2017 Sep 1;20(9):683-691. doi: 10.1093/ijnp/pyx051.
4
[C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT receptors.[C]AZ10419096——一种用于脑5-羟色胺受体成像的完全拮抗剂正电子发射断层显像放射性配体。
Nucl Med Biol. 2017 Nov;54:34-40. doi: 10.1016/j.nucmedbio.2017.07.007. Epub 2017 Jul 21.
5
Serotonin concentration enhancers at clinically relevant doses reduce [C]AZ10419369 binding to the 5-HT receptors in the nonhuman primate brain.在临床相关剂量下,血清素浓度增强剂可降低 [C]AZ10419369 与非人类灵长类动物大脑中 5-HT 受体的结合。
Transl Psychiatry. 2018 Jul 16;8(1):132. doi: 10.1038/s41398-018-0178-7.
6
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.在非人类灵长类动物和人类受试者中,AZD3783 与脑 5-HT1B 受体的剂量依赖性结合:使用 [11C]AZ10419369 的正电子发射断层扫描研究。
Psychopharmacology (Berl). 2011 Feb;213(2-3):533-45. doi: 10.1007/s00213-011-2165-z. Epub 2011 Jan 15.
7
Cerebral serotonin release correlates with [C]AZ10419369 PET measures of 5-HT receptor binding in the pig brain.大脑中血清素的释放与猪脑 5-HT 受体结合的 [C]AZ10419369 PET 测量结果相关。
J Cereb Blood Flow Metab. 2018 Jul;38(7):1243-1252. doi: 10.1177/0271678X17719390. Epub 2017 Jul 7.
8
Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study.视觉刺激引起枕叶皮层的血清素释放:一项正电子发射断层扫描/磁共振成像研究。
Hum Brain Mapp. 2020 Nov;41(16):4753-4763. doi: 10.1002/hbm.25156. Epub 2020 Aug 19.
9
Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release.评估新型 5-HT1B 放射性配体 [¹¹C]p943 对内源性血清素释放的敏感性。
Synapse. 2011 Oct;65(10):1113-7. doi: 10.1002/syn.20942. Epub 2011 May 3.
10
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.[11C]AZ10419369:一种适用于正电子发射断层扫描(PET)的选择性5-HT1B受体放射性配体。在灵长类动物大脑中的特性研究。
Neuroimage. 2008 Jul 1;41(3):1075-85. doi: 10.1016/j.neuroimage.2008.02.063. Epub 2008 Mar 14.

引用本文的文献

1
Direct serotonin release in humans shapes aversive learning and inhibition.人类中直接的血清素释放塑造了厌恶学习和抑制。
Nat Commun. 2024 Aug 9;15(1):6617. doi: 10.1038/s41467-024-50394-x.
2
[F]F13640, a 5-HT Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations.[F]F13640,一种对脑血清素波动敏感的5-羟色胺受体放射性药物。
Front Neurosci. 2021 Mar 8;15:622423. doi: 10.3389/fnins.2021.622423. eCollection 2021.
3
Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study.视觉刺激引起枕叶皮层的血清素释放:一项正电子发射断层扫描/磁共振成像研究。
Hum Brain Mapp. 2020 Nov;41(16):4753-4763. doi: 10.1002/hbm.25156. Epub 2020 Aug 19.
4
A randomized placebo-controlled PET study of ketamine´s effect on serotonin receptor binding in patients with SSRI-resistant depression.一项随机安慰剂对照 PET 研究氯胺酮对 SSRI 抵抗性抑郁症患者血清素受体结合的影响。
Transl Psychiatry. 2020 Jun 1;10(1):159. doi: 10.1038/s41398-020-0844-4.
5
Inverse changes in raphe and cortical 5-HT receptor availability after acute tryptophan depletion in healthy human subjects.健康人体中急性色氨酸耗竭后中缝核和皮质 5-HT 受体可用性的反向变化。
Synapse. 2020 Oct;74(10):e22159. doi: 10.1002/syn.22159. Epub 2020 May 7.
6
Serotonin concentration enhancers at clinically relevant doses reduce [C]AZ10419369 binding to the 5-HT receptors in the nonhuman primate brain.在临床相关剂量下,血清素浓度增强剂可降低 [C]AZ10419369 与非人类灵长类动物大脑中 5-HT 受体的结合。
Transl Psychiatry. 2018 Jul 16;8(1):132. doi: 10.1038/s41398-018-0178-7.
7
Potential Effect of Prolonged Sevoflurane Anesthesia on the Kinetics of [C]Raclopride in Non-human Primates.七氟醚麻醉时间延长对非人类灵长类动物 [C]罗匹尼罗药代动力学的潜在影响。
Mol Imaging Biol. 2018 Apr;20(2):183-187. doi: 10.1007/s11307-017-1120-8.
8
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.芬氟拉明降低非人类灵长类动物大脑中 [11C]Cimbi-36 与 5-HT2A 受体的结合。
Int J Neuropsychopharmacol. 2017 Sep 1;20(9):683-691. doi: 10.1093/ijnp/pyx051.
9
Cerebral serotonin release correlates with [C]AZ10419369 PET measures of 5-HT receptor binding in the pig brain.大脑中血清素的释放与猪脑 5-HT 受体结合的 [C]AZ10419369 PET 测量结果相关。
J Cereb Blood Flow Metab. 2018 Jul;38(7):1243-1252. doi: 10.1177/0271678X17719390. Epub 2017 Jul 7.
10
Cerebral 5-HT release correlates with [C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain.大脑5-羟色胺释放与猪脑中5-羟色胺2A受体占有率的[C]Cimbi36正电子发射断层扫描测量结果相关。
J Cereb Blood Flow Metab. 2017 Feb;37(2):425-434. doi: 10.1177/0271678X16629483. Epub 2016 Jul 20.

本文引用的文献

1
Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubis.在 Papio anubis 中进行的 [11C] P943 正电子发射断层扫描研究:体内药理学特性和对内源性 5-羟色胺敏感性的特征
Synapse. 2011 Nov;65(11):1119-27. doi: 10.1002/syn.20946. Epub 2011 May 19.
2
Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release.评估新型 5-HT1B 放射性配体 [¹¹C]p943 对内源性血清素释放的敏感性。
Synapse. 2011 Oct;65(10):1113-7. doi: 10.1002/syn.20942. Epub 2011 May 3.
3
Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds.开发用于中枢 5-HT1B 受体的 PET 放射性配体:8 种放射性标记化合物在食蟹猴中的放射合成和表征。
Nucl Med Biol. 2011 Feb;38(2):261-72. doi: 10.1016/j.nucmedbio.2010.08.006. Epub 2010 Dec 3.
4
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.在非人类灵长类动物和人类受试者中,AZD3783 与脑 5-HT1B 受体的剂量依赖性结合:使用 [11C]AZ10419369 的正电子发射断层扫描研究。
Psychopharmacology (Berl). 2011 Feb;213(2-3):533-45. doi: 10.1007/s00213-011-2165-z. Epub 2011 Jan 15.
5
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.通过发射型计算机断层扫描测量内源性 5-HT 释放:前景与挑战。
J Cereb Blood Flow Metab. 2010 Oct;30(10):1682-706. doi: 10.1038/jcbfm.2010.104. Epub 2010 Jul 28.
6
In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.体内 [11C]CUMI-101 与血清素 1A 受体激动剂的结合:正电子发射断层扫描放射性示踪剂。
J Cereb Blood Flow Metab. 2011 Jan;31(1):243-9. doi: 10.1038/jcbfm.2010.83. Epub 2010 Jun 23.
7
Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain.对人脑 5-HT1B 受体与[11C]AZ10419369 结合的定量分析。
J Cereb Blood Flow Metab. 2011 Jan;31(1):113-23. doi: 10.1038/jcbfm.2010.55. Epub 2010 Apr 28.
8
Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain.芬氟拉明诱导的血清素释放降低了灵长类动物大脑中 5-HT1B 受体对 [11C]AZ10419369 的结合。
Synapse. 2010 Jul;64(7):573-7. doi: 10.1002/syn.20780.
9
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.使用HRRT通过3D-OP-OSEM点扩散函数重建进行PET定量分析的进展。
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1639-50. doi: 10.1007/s00259-009-1156-3. Epub 2009 May 13.
10
[N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.[甲基-³H₃]AZ10419369与5-HT1B受体的结合:体外特性及体内受体占有率
J Pharmacol Exp Ther. 2009 Jul;330(1):342-51. doi: 10.1124/jpet.109.150722. Epub 2009 Apr 28.

采用平衡法确认芬氟拉明对 [(11)C]AZ10419369 与 5-HT(1B) 受体结合的影响。

Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach.

机构信息

Psychiatry Section, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

出版信息

J Cereb Blood Flow Metab. 2012 Apr;32(4):685-95. doi: 10.1038/jcbfm.2011.172. Epub 2011 Dec 14.

DOI:10.1038/jcbfm.2011.172
PMID:22167236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3318146/
Abstract

Assessment of serotonin release in the living brain with positron emission tomography (PET) may have been hampered by the lack of suitable radioligands. We previously reported that fenfluramine caused a dose-dependent reduction in specific binding in monkeys using a classical displacement paradigm with bolus administration of [(11)C]AZ10419369. The aim of this study was to confirm our previous findings using an equilibrium approach in monkey. A total of 24 PET measurements were conducted using a bolus infusion protocol of [(11)C]AZ10419369 in three cynomolgus monkeys. Initial PET measurements were performed to assess suitable K(bol) values. The fenfluramine effect on [(11)C]AZ10419369 binding was evaluated in a displacement and pretreatment paradigm. The effect of fenfluramine on [(11)C]AZ10419369 binding potential (BP(ND)) was dose-dependent in the displacement paradigm and confirmed in the pretreatment paradigm. After pretreatment administration of fenfluramine (5.0 mg/kg), the mean BP(ND) of the occipital cortex decreased by 39%, from 1.38±0.04 to 0.84±0.09. This study confirms that the new 5-HT(1B) receptor radioligand [(11)C]AZ10419369 is sensitive to fenfluramine-induced changes in endogenous serotonin levels in vivo. The more advanced methodology is suitable for exploring the sensitivity limit to serotonin release as measured using [(11)C]AZ10419369 and PET.

摘要

使用正电子发射断层扫描(PET)评估活脑中的血清素释放可能因缺乏合适的放射性配体而受到阻碍。我们之前报道过,使用经典的脉冲式给药取代研究范式,在猴子中,芬氟拉明会导致(11C)AZ10419369 的特异性结合呈剂量依赖性减少。本研究旨在使用猴子的平衡方法来证实我们之前的发现。在三只食蟹猴中,通过(11C)AZ10419369 的脉冲输注方案进行了总共 24 次 PET 测量。最初的 PET 测量是为了评估合适的 Kbol 值。使用置换和预处理范式评估了芬氟拉明对(11C)AZ10419369 结合的影响。在置换范式中,芬氟拉明对(11C)AZ10419369 结合潜能(BP(ND))的影响呈剂量依赖性,并在预处理范式中得到了证实。在给予芬氟拉明(5.0mg/kg)预处理后,枕叶皮质的平均 BP(ND)下降了 39%,从 1.38±0.04 降至 0.84±0.09。本研究证实,新型 5-HT1B 受体放射性配体(11C)AZ10419369 对体内内源性血清素水平的芬氟拉明诱导变化敏感。更先进的方法学适合探索使用(11C)AZ10419369 和 PET 测量的血清素释放的敏感性极限。